Patents by Inventor Nasoff Marc

Nasoff Marc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal Antibodies and Methods of Use
    Publication number: 20150125453
    Abstract: This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs.
    Type: Application
    Filed: October 25, 2012
    Publication date: May 7, 2015
    Applicant: Novartis AG
    Inventors: Sarah Rue, Eckelman Brendan, Deveraux Quinn, Nasoff Marc